Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy | Vertex Pharmaceuticals Newsroom – news.vrtx.com December 13, 2023
Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery – Yahoo Finance July 13, 2023
Rapper Young Thug, co-defendant ara accused of in-court drug transaction January 21, 2023January 21, 2023
First cases of gonorrhea resistant to several classes of antibiotics identified in the U.S. January 20, 2023January 19, 2023
CDC identifies possible safety issue with Pfizer’s updated Covid-19 vaccine but says people should still get boosted January 14, 2023January 13, 2023
Updated childhood obesity treatment guidelines include medications, surgery for some young people January 9, 2023January 9, 2023